InvestorsHub Logo
Followers 37
Posts 20323
Boards Moderated 0
Alias Born 07/10/2015

Re: joev2 post# 17370

Saturday, 07/28/2018 8:29:49 PM

Saturday, July 28, 2018 8:29:49 PM

Post# of 41365
Well Joe you have 2 choices. Believe the stockprice fairly represents the company and its tech or not. Based on all the evidence ive seen, marketcap doesnt even come close to the companies true value. What ultimately determines that for me is the sheer market size of the tech. The tech isnt some future promise to deliver. Its been created, its being sold in a fraction of its potential market, & all studies clinical, animal, & in vivo confirm its superiority. Not only that but Amedica has several large companies that are partnered with it including Zimmer, Kyocera, NGK, Dentsply, Morgan Ceramics & more that havent been disclosed.

Again evaluate the tech, evaluate financials, evaluate partnerships, nothing indicates penny stock except its marketcap and that is easily manipulated. He who controls the stockprice controls the narrative.

Among the most prevalent and up-to-date phrases in business, politics and savvy American life is "controlling the narrative."

That is, telling it your way, before someone else gets to tell it — and possibly tell it better — their way. And getting the public to relate to you on a more intimate level: In a social-media world, being impersonal is being out of it.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SINT News